# Levothyroxine Sodium Tablets - In Vivo Pharmacokinetic and Bioavailability Studies and In Vitro Dissolution Testing - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/levothyroxine-sodium-tablets-in-vivo-pharmacokinetic-and-bioavailability-studies-and-in-vitro-dissolution-testing/74b4ee28-e27e-400e-8b87-ba8701d4ea31

> FDA guidance document: Levothyroxine Sodium Tablets - In Vivo Pharmacokinetic and Bioavailability Studies and In Vitro Dissolution Testing. Issue date: March 08, 2001. Get complete insights and analysis.

---

## Details

- Title: Levothyroxine Sodium Tablets - In Vivo Pharmacokinetic and Bioavailability Studies and In Vitro Dissolution Testing
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2001-03-08
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1999-D-0010">FDA-1999-D-0010</a>

## Related Documents

- [Prussian Blue Drug Products — Submitting a New Drug Application](https://www.globalkeysolutions.net/guidances/guidance-document/prussian-blue-drug-products-submitting-a-new-drug-application/50eeb151-80bd-4aa2-8526-e3d53b652af5)
- [Alternate Source of the Active Pharmaceutical Ingredient in Pending ANDAs:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/alternate-source-of-the-active-pharmaceutical-ingredient-in-pending-andas-guidance-for-industry/8a3da1bc-1ebb-48aa-a3ea-7662562c4370)
- [INDs for Phase 2 and Phase 3 Studies Chemistry, Manufacturing, and Controls Information:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/inds-for-phase-2-and-phase-3-studies-chemistry-manufacturing-and-controls-information-guidance-for-industry/f47444ad-ffd7-42ea-816d-1d6da8a15bf1)